Hava Gil-Henn

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Cell Proliferation

Staphylococcus Aureus

Top Venues

Cancer research communications

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ankita P Sankar, Hyun-Mi Cho, Seung-Uon Shin, Tal Sneh, Sundaram Ramakrishnan, Christian Elledge, Yu Zhang, Rathin Das, Hava Gil-Henn, Joseph D Rosenblatt
Antibody-drug conjugate αEGFR-E-P125A reduces triple-negative breast cancer vasculogenic mimicry, motility, and metastasis through inhibition of EGFR, integrin, and FAK/STAT3 signaling. Cancer research communications (2024)
Ankita P Sankar, Hyun-Mi Cho, Seung-Uon Shin, Tal Sneh, Sundaram Ramakrishnan, Christian Elledge, Yu Zhang, Rathin Das, Hava Gil-Henn, Joseph D Rosenblatt
Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling. Cancer research communications 4 (3) (2024)
Ankita P Sankar, Hyun-Mi Cho, Seung-Uon Shin, Tal Sneh, Sundaram Ramakrishnan, Christian Elledge, Yu Zhang, Rathin Das, Hava Gil-Henn, Joseph D Rosenblatt
Antibody-drug conjugate αEGFR-E-P125A reduces triple-negative breast cancer vasculogenic mimicry, motility, and metastasis through inhibition of EGFR, integrin, and FAK/STAT3 signaling. Cancer research communications (2024)
Shams Twafra, Chana G Sokolik, Tal Sneh, Kolluru D Srikanth, Tomer Meirson, Alessandro Genna, Jordan H Chill, Hava Gil-Henn
Correction: A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis. Oncogene (2022)
Trishna Saha Detroja, Hava Gil-Henn, Abraham O Samson
Text-Mining Approach to Identify Hub Genes of Cancer Metastasis and Potential Drug Repurposing to Target Them. Journal of clinical medicine 11 (8) (2022)
Bisan Saleh, Kolluru D Srikanth, Tal Sneh, Lambert Yue, Steven Pelech, Evan Elliott, Hava Gil-Henn
FAK-Mediated Signaling Controls Amyloid Beta Overload, Learning and Memory Deficits in a Mouse Model of Alzheimer's Disease. International journal of molecular sciences 23 (16) (2022)
Shams Twafra, Chana G Sokolik, Tal Sneh, Kolluru D Srikanth, Tomer Meirson, Alessandro Genna, Jordan H Chill, Hava Gil-Henn
Correction: A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis. Oncogene (2022)
Shams Twafra, Chana G Sokolik, Tal Sneh, Kolluru D Srikanth, Tomer Meirson, Alessandro Genna, Jordan H Chill, Hava Gil-Henn
A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis. Oncogene (2022)
Seung-Uon Shin, Hyun-Mi Cho, Rathin Das, Hava Gil-Henn, Sundaram Ramakrishnan, Ahmed Al Bayati, Stephen F Carroll, Yu Zhang, Ankita P Sankar, Christian Elledge, Augustin Pimentel, Marzenna Blonska, Joseph D Rosenblatt
Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases. Cells 10 (11) (2021)
Trishna Saha Detroja, Jonathan Solomon, Abraham O Samson, Hava Gil-Henn
Invasion and Metastasis as a Central Hallmark of Breast Cancer. Journal of clinical medicine 10 (16) (2021)
Trishna Saha Detroja, Hava Gil-Henn
Invadopodia, a Kingdom of Non-Receptor Tyrosine Kinases. Cells 10 (8) (2021)
Jonathan Solomon, Magdalena Raškova, Daniel Rosel, Jan Brabek, Hava Gil-Henn
Are We Ready for Migrastatics? Cells 10 (8) (2021)
Shannon L Gourley, Kolluru D Srikanth, Ellen P Woon, Hava Gil-Henn
Pyk2 Stabilizes Striatal Medium Spiny Neuron Structure and Striatal-Dependent Action. Cells 10 (12) (2021)
Alessandro Genna, Stefanie Lapetina, Nikola Lukic, Shams Twafra, Tomer Meirson, Ved P Sharma, John S Condeelis, Hava Gil-Henn
Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells. The Journal of cell biology 217 (1) (2017)